Timothy James Shoemaker, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1703 W Stones Crossing Rd Ste 200, Greenwood, IN 46143 Phone: 317-859-3737 |
News Archive
Women with hereditary breast cancer treated with breast conserving therapy appear to have no increased risk for recurrence in the treated breast, according to results from a prospective study published in the January 1, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Former President Bill Clinton and U.N. Secretary-General Ban Ki-moon in New York on Thursday launched MASSIVEGOOD - an initiative that allows travelers to make a $2 donation "to fight deadly diseases whenever they buy a plane ticket, book a hotel room or rent a car," Bloomberg/BusinessWeek reports (Varner, 3/4).
Osiris Therapeutics, Inc. today announced that results from the Phase III trial evaluating Prochymal for the treatment of steroid-refractory acute graft vs. host disease (GvHD) will be presented by Paul Martin, M.D., of the Fred Hutchinson Cancer Research Center and Paul Szabolcs, M.D., of Duke University Medical Center at the 2010 BMT Tandem Meeting. The meeting is being held February 24-28 in Orlando, Florida.
"Signaling South Korea may be attempting to cool tensions with its neighbor, Seoul has vowed to actively review sending humanitarian aid to North Korea through third channels," CNN reports.
A new drug, edifoligide, designed to prevent the clogging of veins used in coronary bypass surgery was no more effective than a placebo, according to the results of a Phase III clinical trial led by researchers at Duke Clinical Research Institute (DCRI).
› Verified 5 days ago